Table 4.
Laboratory tests in patients with STEMI
| Total (n = 340) Median (IQR) | PS (n = 166) Median (IQR) | PPCI (n = 174) Median (IQR) | p | |
|---|---|---|---|---|
| Hemoglobin (g/L) | 15.6 (14.4-16.7) | 15.35 (14.4-16.3) | 15.8 (14.5-16.9) | 0.08 |
| Creatinine (mg/dL) | 1 (0.8-1.2) | 1 (0.8-1.2) | 1 (0.8-1.1) | 0.99 |
| Urea nitrogen (mg/dL) | 17 (14-23) | 18.1 (15-25) | 16.6 (14-21) | 0.04 |
| Na (mEq/L) | 136 (134-138) | 136 (134-138) | 136 (134-137) | 0.30 |
| C reactive protein (mg/L) | 6.9 (2.7-28.7) | 13.06 (4.26-46) | 4.5 (2-19) | 0.00 |
| Leukocytes (103/µL) | 11.7 (9.3-14.4) | 11.4 (9.3-14.7) | 11.9 (9.2-14.2) | 0.82 |
| NT-PROBNP (pg/mL) | 793.5 (222.5-3284.5) | 1445 (421-3643) | 389 (100.5-2644) | 0.00 |
| Troponin I (ng/mL) | 12.7 (0.9-52.8) | 35 (12-80) | 1.85 (0.3-14.9) | 0.00 |
| Maximum Troponin I (ng/mL) | 64 (24-80) | 67.9 (23.8-80) | 62.9 (26-80) | 0.46 |
| Glucose (mg/dL) | 162.5 (1278-238.5) | 150 (115-230) | 174 (136-246.8) | 0.00 |
| K (mEq/L) | 4.1 (3.8-4.4) | 4.1 (3.86-4.5) | 4.1 (3.8-4.4) | 0.07 |
| Cl (mEq/L) | 103 (100-105.52) | 103 (101-107) | 103 (100-105) | 0.30 |
| Glycated hemoglobin (%) | 6.1 (5.65-8.2) | 6.1 (5.6-7.6) | 6.1 (5.7-8.3) | 0.41 |
| Albumin (g/dL) | 3.6 (3.3-3.9) | 3.6 (3.4-4) | 3.7 (3.4-3.9) | 0.88 |
| Uric acid (mg/dL) | 6.7 (5.6-7.86) | 6.8 (5.8-8.1) | 6.4 (5.4-7.8) | 0.03 |
| Platelets (103/µL) | 217 (183-259) | 209.5 (177-257) | 221.5 (192-263) | 0.10 |
| Cholesterol (mg/dL) | 154.9 (130-188.9) | 153 (129.5-186) | 157 (131-189) | 0.36 |
| LDL Cholesterol (mg/dL) | 98.3 (75-121.8) | 99.9 (74.4-121) | 97.2 (75.8-122.6) | 0.72 |
| HDL Cholesterol (mg/dL) | 34.4 (29.7-40) | 34.3 (29.2-40.3) | 34.5 (30.7-40) | 0.33 |
| STH (mIU/L) | 1.4 (0.7-2.8) | 1.35 (0.9-2.8) | 1.4 (0.7-2.9) | 0.88 |
PS: pharmacoinvasive strategy; PPCI: primary percutaneous coronary intervention; SD: standard deviation; IQR: interquartile range; LDL: low density lipoprotein; HDL: high density lipoprotein; STH: stimulant thyroid hormone.